FBRX.D

Forte Biosciences, Inc.

Healthcare · Biotechnology

$285.59 sample

+4.32 (+1.54%) 1D

Market cap

$1.24T

Price as of

2026-10-24

Latest filing

8-K · 2026-09-30

Alerts

8

Price$285.59 +6.74% 3M daily closessample

290.38263.55

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20INSInsider sell: Chief Executive Officer
Oct 09INSInsider sell: EVP, Operations
Sep 30SEC8-K filed: material event
Sep 24INSInsider sell: Chief Financial Officer
Sep 17INSInsider sell: Chief Financial Officer
Sep 14INSInsider sell: General Counsel
Sep 04SEC8-K filed: material event
Sep 01INSInsider buy: General Counsel

Sign up to see the real FBRX.D record →

Company facts

SEC EDGAR registration

Name: Forte Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -3sample, -100 to +100
Reporting currency: USD

Who is positioning in FBRX.D

sample

Insiders: 23 insider transactions over 90 days, net selling, $129.8M
Congress: 3 members traded over 90 days
Institutions · 13F: 10 funds hold $22.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$57.5B +16.4% y/y

Q4 2024Q3 2026

Inventory$32.1B +8.3% y/y

Q4 2024Q3 2026

Accounts receivable$24.6B +7.8% y/y

Q4 2024Q3 2026

Total debt$67.6B +15.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $751.9B -12.8% 3M
Sample peer B: $631.5B +3.3% 3M
Sample peer C: $632.4B +16.0% 3M
Sample peer D: $680.7B +8.5% 3M
Sample peer E: $984.0B +10.0% 3M